Reported by 1 source

The short version

  • Researchers identified a protein in American bullfrogs that binds to saxitoxin, preventing it from affecting the nervous system.
  • In mouse trials, the protein successfully neutralized lethal doses of the toxin even when administered after exposure.
  • While results are promising, significant hurdles remain before the treatment can be tested for safety and efficacy in humans.

Paralytic shellfish poisoning remains a severe global health threat with no existing antidote, but new research suggests a protein found in American bullfrogs could eventually change that reality. The condition is caused by saxitoxin, a potent neurotoxin produced by harmful algal blooms commonly known as red tides. These blooms occur when warm weather and sunlight trigger excessive algae growth in ocean waters worldwide. When shellfish filter-feed on these organisms, they accumulate the toxin, which then poses a lethal risk to humans who consume contaminated seafood.

Saxitoxin is so dangerous that it was stockpiled by the United States during the Cold War and is now classified as a chemical weapon under international law. The poison attacks the nervous system by blocking sodium ion channels on cell surfaces, which are critical for nerve communication and muscle contraction. Symptoms can appear within thirty minutes of eating contaminated food and include nausea, vomiting, numbness, high blood pressure, and paralysis. Death can occur just hours after ingestion, with a fatality rate of approximately 8.5 percent among those who become ill.

News Journal

A study published in Nature Communications on July 16 details how saxiphilin, a protein produced by American bullfrogs, may offer a solution. Daniel Minor, a biophysicist at the University of California, San Francisco, and his colleagues investigated whether this protein could protect against the toxin. Scientists had long suspected that amphibians like bullfrogs resist saxitoxin because the protein binds to it, but this new work provides a concrete pathway for developing therapeutic interventions.

The researchers conducted experiments on mice to test the efficacy of saxiphilin. In control groups, thirteen animals received injections of lethal doses of saxitoxin and nearly all developed limb paralysis within three minutes, dying shortly thereafter. However, when mice were given saxiphilin before, during, or after exposure to the toxin, the outcomes changed drastically. Notably, administering a single injection of the protein just one minute after poisoning allowed nine out of ten tested mice to survive without suffering lethal effects.

Minor describes the protein as acting like a molecular sponge that steals the toxin from the body. Analysis of the mice revealed that saxiphilin levels were highest in the kidneys, followed by the heart and liver, with smaller but significant amounts reaching the brain and skeletal muscle. This distribution helps explain how the protein protects against paralysis, as it prevents the toxin from reaching ion channels and facilitates its transport out of the body for destruction or excretion.

Rebecca Tarvin, an evolutionary biologist at the University of California, Berkeley who was not involved in the study, praised the comprehensive nature of the research. She noted that the team evaluated three distinct applications: prevention before poisoning, neutralization while mixed with the toxin, and rescue after exposure. This multi-faceted approach provides a robust initial assessment of the protein's potential for therapeutic use.

Despite these promising results in animal models, significant challenges remain before saxiphilin can be considered a viable treatment for humans. Tarvin emphasized that there is a substantial gap between efficacy in mice and developing safe treatments for people. Further research is required to ensure the protein works against various types of paralytic shellfish toxins and to determine the most effective delivery methods for human patients.

The implications of this discovery extend beyond shellfish poisoning. Minor hopes the findings will inspire scientists to look for antidotes to other natural toxins by studying how different organisms have evolved resilience to poisons. With nature having solved these problems multiple times across the biological world, researchers believe there may be untapped potential in other species for developing life-saving treatments.

Currently, around 2,000 people worldwide fall ill from paralytic shellfish poisoning each year. Cooking or freezing seafood does not destroy saxitoxin, and affected shellfish appear, smell, and taste normal, making prevention difficult. Until a reliable antidote is developed for human use, public health officials continue to rely on monitoring algal blooms and issuing advisories to protect consumers from contaminated seafood.

Sources behind this briefing

Go to the original reporting

  • Smithsonian Magazine↗This Deadly Shellfish Poisoning Has No Antidote. A Protein Found in American Bullfrogs Could Change That